Status:
COMPLETED
Statistical Analysis of Prevalence, Incidence, Comorbidities and Medical Expense in Epileptic Children in Taiwan Based on National Health Research Insurance Database.
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Neurologic Disorder
Seizure Disorder
Eligibility:
All Genders
Up to 19 years
Brief Summary
Epilepsy is a common disease in pediatric neurology. In recent years, due to the promotion of Taiwan's health insurance and the advancement of related medical treatments and anti-epileptic drugs, the ...
Eligibility Criteria
Inclusion
- Targets aged 0\~19 (\<=19) in the home country
- Diagnosis code includes ICD9: 345.XX, ACODE:A225 (including outpatient and inpatient)
- Between 2001 and 2013, those who had seen a doctor three times in a row with epilepsy diagnosis codes and used anti-epileptic drugs
Exclusion
- Exclude those who sought medical treatment for epilepsy from 2001 to 2013, but the number of medical visits (outpatient + hospitalization) \<3 times, and exclude those who did not take medication from 2001 to 2013.
Key Trial Info
Start Date :
March 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 19 2021
Estimated Enrollment :
169026 Patients enrolled
Trial Details
Trial ID
NCT06542952
Start Date
March 9 2018
End Date
February 19 2021
Last Update
August 7 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Tainan, Taiwan, 100
2
Department of Pediatrics, National Taiwan University Hospital
Taipei, Taiwan